The US Generics market has been witnessing significant pricing pressure leading to significant losses at Jubilant Cadista since FY2022 onwards.
FDA has concluded that this inspection is 'closed'
The company currently supplies one product to the US market that contributes low- single digit revenue to Jubilant Pharmova revenue
He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets
Post this currently only Risperidone orally disintegrating tablets are allowed for import into the US from the Roorkee facility.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)